Skip to Main Content

Terri Parker, MD

Assistant Professor of Medicine (Hematology)
DownloadHi-Res Photo

Additional Titles

Assistant Medical Director, Smilow Cancer Hospital, North Haven

About

Titles

Assistant Professor of Medicine (Hematology)

Assistant Medical Director, Smilow Cancer Hospital, North Haven

Biography

Terri Parker, MD, is an Assistant Professor of Medicine at the Yale School of Medicine in the section of Hematology. Dr. Parker completed her internal medicine residency at the University of Connecticut followed by a fellowship program in hospice and palliative medicine. She also completed a fellowship in hematology and medical oncology at Yale University School of Medicine.

Dr. Parker serves as the assistant medical director at Smilow Cancer Hospital in North Haven. She is a member of the protocol review committee (PRC) at Yale Cancer Center, which is charged with the scientific evaluation of all cancer clinical protocols and amendments proposed at Yale prior to initiation. Dr. Parker currently serves as co-chair of the Multiple Myeloma Committee for ClinicalPath, which presents evidence-based oncology pathways to academic and community practices.

Dr. Parker treats patients with plasma cell dyscrasias, including multiple myeloma and related diseases such as AL amyloidosis, monoclonal gammopathy of undetermined significance (MGUS), plasma cell leukemia, smoldering multiple myeloma, and Waldenstrom’s macroglobulinemia. She has experience with clinical trials focused on novel therapies and drug combinations with a goal of advancing the standard of care for patients with AL amyloidosis, newly diagnosed and relapsed refractory multiple myeloma.

Learn more about Dr. Parker>>

Appointments

Other Departments & Organizations

Education & Training

Fellowship
Yale University School of Medicine (2012)
Fellowship
University of Connecticut Health Center (2009)
Residency
University of Connecticut Health Center (2008)
MD
St. George's University School of Medicine Grenada (2005)
BS
University of Pittsburgh (2001)

Research

Overview

Medical Subject Headings (MeSH)

Hematology; Multiple Myeloma

Research at a Glance

Yale Co-Authors

Frequent collaborators of Terri Parker's published research.

Publications

2024

2021

2020

Clinical Trials

Academic Achievements & Community Involvement

  • activity

    Protocol Review Committee, Yale Cancer Center, Yale University School of Medicine

  • activity

    American Society of Hematology

  • activity

    Faculty Advisory Council, Yale University School of Medicine

  • honor

    David S. Fischer Teaching Award for Outstanding Faculty Teaching and Mentoring of Fellows in Medical Oncology

  • honor

    Letter of Recognition from Evaluation and Promotions Committee

Clinical Care

Overview

Terri Parker, MD, is a hematologist and assistant medical director at the Smilow Cancer Hospital Care Center in North Haven.

Dr. Parker treats patients with plasma cell dyscrasias, including multiple myeloma, and related diseases such as AL amyloidosis, monoclonal gammopathy of undetermined significance (MGUS), plasma cell leukemia, smoldering multiple myeloma, and Waldenstrom’s macroglobulinemia.

“These are all disorders where the primary abnormality is in the plasma cell. Plasma cells are a type of white blood cell,” Dr. Parker explains. “I was drawn to hematology because it isn’t just one organ system involved. It touches on everything. And I love the continuity of care it provides as I get to know my patients.”

Dr. Parker says she is encouraged by the advances that have been made in recent years in terms of new therapies for conditions like multiple myeloma. “Right now, there isn’t a cure for multiple myeloma, but it’s very treatable,” she says.

She says she also enjoys the team aspect of her job. “It isn’t just me a patient sees but there is a whole team caring for the patient including advanced practice providers such as physician’s assistants, other myeloma specialists, a dedicated pharmacist, social worker, and a nutritionist. There is also a support group for patients,” she says.

Dr. Parker’s research interests focus on novel therapies and drug combinations to improve care for patients with AL amyloidosis, newly diagnosed and relapsed refractory multiple myeloma.

Clinical Specialties

Hematologic Oncology; Hematology

Fact Sheets

Board Certifications

  • Medical Oncology

    Certification Organization
    AB of Internal Medicine
    Latest Certification Date
    2015
    Original Certification Date
    2013
  • Hematology (Internal Medicine)

    Certification Organization
    AB of Internal Medicine
    Original Certification Date
    2012

Yale Medicine News

Get In Touch

Contacts

Appointment Number
Clinic Fax Number

Administrative Support

Locations

  • Patient Care Locations

    Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.